Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Generation of allogeneic and xenogeneic functional muscle stem cells for intramuscular transplantation
Ajda Lenardič, … , Christoph Handschin, Ori Bar-Nur
Ajda Lenardič, … , Christoph Handschin, Ori Bar-Nur
Published May 7, 2024
Citation Information: J Clin Invest. 2024;134(12):e166998. https://doi.org/10.1172/JCI166998.
View: Text | PDF
Research Article Muscle biology Article has an altmetric score of 9

Generation of allogeneic and xenogeneic functional muscle stem cells for intramuscular transplantation

  • Text
  • PDF
Abstract

Satellite cells, the stem cells of skeletal muscle tissue, hold a remarkable regeneration capacity and therapeutic potential in regenerative medicine. However, low satellite cell yield from autologous or donor-derived muscles hinders the adoption of satellite cell transplantation for the treatment of muscle diseases, including Duchenne muscular dystrophy (DMD). To address this limitation, here we investigated whether satellite cells can be derived in allogeneic or xenogeneic animal hosts. First, injection of CRISPR/Cas9-corrected Dmdmdx mouse induced pluripotent stem cells (iPSCs) into mouse blastocysts carrying an ablation system of host satellite cells gave rise to intraspecies chimeras exclusively carrying iPSC-derived satellite cells. Furthermore, injection of genetically corrected DMD iPSCs into rat blastocysts resulted in the formation of interspecies rat-mouse chimeras harboring mouse satellite cells. Notably, iPSC-derived satellite cells or derivative myoblasts produced in intraspecies or interspecies chimeras restored dystrophin expression in DMD mice following intramuscular transplantation and contributed to the satellite cell pool. Collectively, this study demonstrates the feasibility of producing therapeutically competent stem cells across divergent animal species, raising the possibility of generating human muscle stem cells in large animals for regenerative medicine purposes.

Authors

Ajda Lenardič, Seraina A. Domenig, Joel Zvick, Nicola Bundschuh, Monika Tarnowska-Sengül, Regula Furrer, Falko Noé, Christine L. Trautmann, Adhideb Ghosh, Giada Bacchin, Pjeter Gjonlleshaj, Xhem Qabrati, Evi Masschelein, Katrien De Bock, Christoph Handschin, Ori Bar-Nur

×

Figure 7

Mouse myoblasts produced in rats restore dystrophin and contribute to the niche in DMD mice.

Options: View larger image (or click on image) Download as PowerPoint
Mouse myoblasts produced in rats restore dystrophin and contribute to th...
(A) Representative immunostaining for dystrophin in tibialis anterior (TA) muscle cross sections of Dmdmdx-4Cv; Prkdcscid mice 4 weeks after transplantation with the indicated cell lines. Scale bars: 1 mm (top) and 100 μm (bottom). (B) Quantification of the transplantation trials shown in A. n = 5 transplantation recipients for intraspecies chimera–derived myoblasts and n = 9 transplantation recipients for interspecies chimera–derived myoblasts. Each dot represents an individual transplanted muscle, with different dot colors specifying 2 different chimera-derived myoblast lines used for transplantations. Data are presented as mean ± SD. Statistical analysis was performed using a Student’s 2-tailed t test. *P ≤ 0.05, ****P ≤ 0.0001. (C) Representative immunostaining images for dystrophin and fiber typing in TA muscle cross sections of Dmdmdx-4Cv; Prkdcscid mice 4 weeks after transplantation with the indicated myoblasts. Scale bars: 1 mm (left) and 100 μm (right). LUTs were individually adjusted. (D) A graph illustrating force measurements during repeated tetanic contractions, showing the decline in TA muscle force of Dmdmdx-4Cv; Prkdcscid mice 4 weeks after transplantation with mouse-mouse and rat-mouse chimera–derived myoblasts compared to PBS control. n = 8 mice measured per group. Data are presented as mean ± SD. Statistical analysis was performed using a mixed effects model. (E) Representative immunostaining of TA muscle cross section from Dmdmdx-4Cv; Prkdcscid mice stained for the indicated markers 4 weeks after transplantation with the specified cell lines. Arrowheads point to colocalization of PAX7 expression and the Pax7-nGFP reporter in rare cells. Scale bars: 100 μm (left) and 25 μm (right). (F) Schematic representation of myoblast re-isolation from transplanted muscles. (G) Representative FACS plots showing the percentage of Pax7-nGFP+ cells detected in digested TA muscles of Dmdmdx-4Cv; Prkdcscid mice at 4 weeks following myoblast transplantation. (H) Representative images of re-isolated myoblasts. Scale bar: 100 μm. (I) PCR for dystrophin in DNA extracted from re-isolated myoblasts. Note the presence of only an edited band in edited and re-isolated myoblasts.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Blogged by 1
Posted by 5 X users
15 readers on Mendeley
See more details